Skip to main content
PZ Cormay S.A. logo

PZ Cormay S.A. — Investor Relations & Filings

Ticker · CRM ISIN · PLCMRAY00029 LEI · 2594006HZJ8OSNK56U87 WAR Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2024-02-09 Regulatory Filings
Country PL Poland
Listing WAR CRM

About PZ Cormay S.A.

https://cormaydiagnostics.com/

PZ Cormay S.A. is a manufacturer and distributor of in-vitro diagnostic (IVD) solutions for medical laboratories and clinics. The company develops, produces, and sells a comprehensive portfolio of diagnostic reagents, laboratory analyzers, and quality control systems. Its offerings cater to key diagnostic areas, including clinical chemistry, hematology, and immunoassay. Key product lines feature the Accent series of chemistry analyzers, the Auryx immunoassay system, and the Mythic family of hematology analyzers. The company integrates its extensive experience in reagent manufacturing with advanced Swiss hematology technology to provide reliable, high-performance, and cost-effective diagnostic tools to a global network of distributors and healthcare professionals.

Recent filings

Filing Released Lang Actions
Zakwalifikowanie do dofinansowania udziału PZ CORMAY S.A. w targach sprzętu medycznego Medica w Dusseldorfie - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is a short announcement from PZ CORMAY S.A. stating that the Polish Agency for Enterprise Development has qualified four of the company's applications for co-financing related to participation as an exhibitor in international medical equipment trade fairs (Medica in Dusseldorf) between 2024 and 2027. This concerns fundraising, financing activities, or capital structure changes related to promotional activities. Given the nature of receiving funding/co-financing for specific projects, the most appropriate category is Capital/Financing Update (CAP). It is not a standard regulatory report (10-K, IR) nor a general regulatory announcement (RNS), but a specific update on securing funds.
2024-02-09 Polish
Terminarz publikacji raportów okresowych PZ CORMAY S.A. w roku 2024 - Content (PL)
Report Publication Announcement Classification · 99% confidence The document text explicitly outlines the schedule for PZ CORMAY S.A. to release its periodic reports (quarterly, semi-annual, and annual) for the year 2024, including specific dates (e.g., May 17, 2024, September 20, 2024, March 29, 2024). This is a forward-looking announcement detailing the timing of future financial report publications, referencing Polish regulatory requirements (§ 62 ust. 1 and § 62 ust. 3 of the Minister of Finance Regulation). This perfectly matches the definition of a Report Publication Announcement (RPA), which announces the timing of report releases, rather than being the report itself. The document length is very short (867 chars), supporting the RPA classification over a full report (like 10-K or IR).
2024-01-31 Polish
Zakwalifikowanie do dofinansowania udziału PZ CORMAY S.A. w targach sprzętu medycznego Medlab Middle East w Dubaju - Content (PL)
Capital/Financing Update Classification · 95% confidence The document text is very short (662 characters) and announces that the Management Board of the Lubelskie Voivodeship has qualified the company's application for co-financing under a specific EU program ('Fundusze Europejskie dla Lubelskiego 2021-2027') to support participation in international medical equipment trade fairs (Medlab Middle East in Dubai). This relates to funding, grants, or capital support for business expansion/participation in events. This fits best under 'Capital/Financing Update' (CAP) as it concerns securing funds/grants for a project, rather than a general regulatory filing (RNS) or a standard financial report.
2024-01-23 Polish
Informacje o statusie przeglądu opcji strategicznych dla projektu PZ CORMAY S.A. Equisse 400i - Content (PL)
Report Publication Announcement Classification · 99% confidence The document is a brief announcement (473 characters) referencing a previous current report (raport bieżący) and providing an update on the timeline for completing a strategic review ('Przegląd Opcji') for a specific product (Equisse 400i). It states that the review is expected to conclude in Q1 2024. Since this is a short update on a strategic process, and not a full financial report (like 10-K or IR) or a formal regulatory filing like a director's dealing or dividend notice, it best fits the general category for regulatory announcements that don't fit elsewhere, or potentially a general update. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a brief, non-standard corporate update, although it could also be seen as a general corporate update. Since it is an update on a strategic process, and not a standard financial report or a specific event like a merger or dividend, RNS serves as the best fit among the provided codes for a general regulatory announcement.
2023-12-29 Polish
Zmiany w Zarządzie PZ CORMAY S.A. - Content (PL)
Board/Management Information Classification · 100% confidence The document text announces a change in senior management within the company (PZ CORMAY S.A.). Specifically, it states that the Supervisory Board dismissed Mr. Flavio Finotello from the position of Vice-President of the Management Board and appointed him as the President of the Management Board. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-12-13 Polish
zal01_M._Sieczek_PZ_CORMAY_S.A_24.11.2023.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details transactions (Nabycie - Acquisition) involving shares (AKCJE) by a person discharging managerial responsibilities (Marcin Sieczek, członek Rady Nadzorczej - member of the Supervisory Board) in the company PZ Cormay Spółka Akcyjna. This structure and content explicitly describe insider trading activity or transactions by management/directors, which corresponds directly to the definition of Director's Dealing.
2023-11-24 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.